Madrigal Pharmaceuticals
MDGL
#2088
Rank
C$12.62 B
Marketcap
C$543.67
Share price
-4.45%
Change (1 day)
-29.64%
Change (1 year)

Earnings for Madrigal Pharmaceuticals (MDGL)

Earnings in 2026 (TTM): -C$0.17 Billion

According to Madrigal Pharmaceuticals 's latest financial reports the company's current earnings are C$1.42 Billion. In 2025 the company made an earning of -C$0.39 Billion, an increase over its 2024 earnings that were of -C$0.65 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Madrigal Pharmaceuticals from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.17 Billion-55.48%
2025 -C$0.39 Billion-41.05%
2024 -C$0.65 Billion25.02%
2023 -C$0.52 Billion23.86%
2022 -C$0.42 Billion20.24%
2021 -C$0.35 Billion17.25%
2020 -C$0.3 Billion117.61%
2019 -C$0.14 Billion189.45%
2018 -C$47.06 Million3.85%
2017 -C$45.32 Million25.71%
2016 -C$36.05 Million-50.81%
2015 -C$73.28 Million-39.14%
2014 -C$0.13 Billion-4.12%
2013 -C$0.13 Billion
2011 -C$65.16 Million23.13%
2010 -C$52.92 Million-145.81%
2009 C$0.11 B-185.95%
2008 -C$0.14 Billion41.52%
2007 -C$94.96 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-C$0.23 Billion 29.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-C$26.04 Million-85.28%๐Ÿ‡บ๐Ÿ‡ธ USA